abstract |
The present invention provides (i) a novel pharmaceutical composition comprising a synergistic combination of a non-digestible fructan-type carbohydrate, i.e. a levan or an inulin (including inulin, oligofructose and mixtures thereof) and an anti-metabolic anti-cancer drug, (ii) said composition for use in the treatment of cancer in non-ruminating mammals, (iii) the use of said combination for the manufacture of a medicament for the treatment of cancer in non-ruminating mammals, and (iv) the use of said composition in a method for treatment of cancer in non-ruminating mammals. |